Contains fulltext : 50651.pdf (publisher's version ) (Closed access)AIMS: To evaluate the feasibility and consequences of lymphatic mapping and a ("repeat") sentinel lymph node (SLN) procedure in patients with breast cancer relapse after previous breast and axillary surgery. METHODS: Review and presentation of a patient cohort. All SLN procedures included lymphoscintigraphy and blue dye injection technique. RESULTS: Twelve cases are described: two patients after a previous SLN procedure and ten after a previous complete axillary lymph node dissection (ALND). Ten patients (83%) had a successful repeat SLN biopsy. After previous ALND, lymphoscintigraphy revealed drainage towards the internal mammary chain in three patients, ...
Background Sentinel node biopsy (SNB) in recurrent breast cancer offers targeted axillary staging co...
Most patients with locally recurrent breast cancer undergo axillary lymph node dissection (ALND). Ho...
Local recurrence (LR) after breast-conservation therapy for breast cancer occurs in 10% to 15% of ca...
AIMS: To evaluate the feasibility and consequences of lymphatic mapping and a ("repeat") sentinel ly...
BACKGROUND: The aim of this study was to investigate the use of sentinel lymph node dissection (SLND...
Knowledge of regional lymph node involvement is important in patients with recurrent breast cancer f...
Background: In a pilot prospective consecutive series on 50 patients with recurrent breast cancer, r...
Purpose. Repeat sentinel node biopsy (SNB) is an alternative to axillary lymph node dissection (ALND...
Ipsilateral breast recurrence or second primary breast cancer can develop in patients who have under...
Ipsilateral breast recurrence or second primary breast cancer can develop in patients who have under...
Axillary staging in patients with locally recurrent breast cancer is important for obtaining locoreg...
Purpose This retrospective study aimed to determine the feasibility, accuracy, and recurrence rates ...
Background: Sentinel lymph node biopsy (SLNB) is a safe and accurate axillary staging procedure for ...
PURPOSE: Sentinel lymph node biopsy (SNB) has been a standard technique in early breast cancer. Howe...
BACKGROUND: To assess the feasibility of lymphatic mapping and determine the lymphatic drainage path...
Background Sentinel node biopsy (SNB) in recurrent breast cancer offers targeted axillary staging co...
Most patients with locally recurrent breast cancer undergo axillary lymph node dissection (ALND). Ho...
Local recurrence (LR) after breast-conservation therapy for breast cancer occurs in 10% to 15% of ca...
AIMS: To evaluate the feasibility and consequences of lymphatic mapping and a ("repeat") sentinel ly...
BACKGROUND: The aim of this study was to investigate the use of sentinel lymph node dissection (SLND...
Knowledge of regional lymph node involvement is important in patients with recurrent breast cancer f...
Background: In a pilot prospective consecutive series on 50 patients with recurrent breast cancer, r...
Purpose. Repeat sentinel node biopsy (SNB) is an alternative to axillary lymph node dissection (ALND...
Ipsilateral breast recurrence or second primary breast cancer can develop in patients who have under...
Ipsilateral breast recurrence or second primary breast cancer can develop in patients who have under...
Axillary staging in patients with locally recurrent breast cancer is important for obtaining locoreg...
Purpose This retrospective study aimed to determine the feasibility, accuracy, and recurrence rates ...
Background: Sentinel lymph node biopsy (SLNB) is a safe and accurate axillary staging procedure for ...
PURPOSE: Sentinel lymph node biopsy (SNB) has been a standard technique in early breast cancer. Howe...
BACKGROUND: To assess the feasibility of lymphatic mapping and determine the lymphatic drainage path...
Background Sentinel node biopsy (SNB) in recurrent breast cancer offers targeted axillary staging co...
Most patients with locally recurrent breast cancer undergo axillary lymph node dissection (ALND). Ho...
Local recurrence (LR) after breast-conservation therapy for breast cancer occurs in 10% to 15% of ca...